MICHELLE SLAVIN: Open Payments
NPI 1619499274 · SOUTHINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$942 in 26 payments from 11 companies in 2025. Trend: 2023 $701 · 2024 $554 · 2025 $942
Food & beverage: $942
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 9 | $264 |
| Sequel Med Tech, LLC | 2 | $191 |
| Medtronic, Inc. | 1 | $114 |
| BETA BIONICS, INC. | 2 | $74 |
| Amgen Inc. | 2 | $61 |
| Abbott Laboratories | 3 | $50 |
| Novo Nordisk Inc | 2 | $49 |
| Mannkind Corporation | 1 | $44 |
| Tandem Diabetes Care, Inc. | 1 | $42 |
| Insulet Corporation | 2 | $30 |
Products named: TWIIST, RECORLEV, MINIMED 780G, GVOKE HYPOPEN, iLet Bionic Pancreas, TEPEZZA, FREESTYLE LIBRE 3, Ozempic.
Industry payments across CT — which companies pay providers there.
